Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Oral PQR309 in Patients With Advanced Solid Tumors

NCT02483858 is registered in ClinicalTrials.gov with PIQUR Therapeutics AG as lead sponsor.

NCT NCT02483858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02483858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Oral PQR309 in Patients With Advanced Solid Tumors
Lead sponsor
PIQUR Therapeutics AG
Phase
Phase 1
Overall status
Completed
Start date
March 21, 2019
Completion date
March 21, 2019
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer